Transparency Market Research Regenerative Medicine Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019
Published Date 2014-07-01
85 Page Report
Buy Now
Request Sample
Press Release
Regenerative Medicine (Bone and Joint) Market Expected to Reach USD 6.5 Billion Globally in 2019 Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com
Regenerative Medicine Market
REPORT DESCRIPTION
Regenerative Medicine Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019 According to a new market research report published by Transparency Market Research “Regenerative Medicine (Bone and Joint) Market (By Technology - Stem Cell Therapy, Biomaterial and Tissue Engineering; By Applications - Bone Graft Substitutes, Osteoarticular Diseases, Allogeneic Products, Autogenic Products and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019� the global regenerative medicine (bone and joint) market was valued at USD 2.6 billion in 2012 and is estimated to reach a market worth of USD 6.5 billion in 2019 growing at a CAGR of 12.8% from 2013 to 2019.
Browse the full Regenerative Medicine Market Report @ : http://www.transparencymarketresearch.com/regenerative-medicinesmarket.html Regenerative medicine is considered as an emerging field of medical science that aims to regenerate, repair or replace damaged tissue and organs. U.S. National Institute of Health stated that regenerative medicine is the process of creating functional tissue to repair and replace tissue or organ which has lost their function due to damage, congenital defects, disease and age. Technological advancement in tissue engineering and stem cell therapy is expected to drive the global market for regenerative medicine (bone and joint). Moreover, growing prevalence of bone and joint disorder has also accounted for the market growth of the global regenerative medicine (bone and joint) market. However, ethical issues pertaining to stem cell therapy and fear of disease transmission due to allogeneic bone implantation are considered as market hindering factors during the study period. Companies operating in this market focus on investing in emerging economies of Asia-Pacific such as India, China, Japan and South Korea. These economies represent huge potential for various bone and joint reconstructive products due to rising healthcare expenditure and presence of large patient pool suffering from arthritis disorder (rheumatoid arthritis).
Transparency Market Research
2
Regenerative Medicine Market
The global market for regenerative medicine is segmented based on technology as stem cell therapy, biomaterials and tissue engineering. In 2012, biomaterials segment accounted for the largest market share in the global regenerative medicine (bone and joint) market owing to favorable reimbursement policies and strong demand of biomaterials in the global market. However, high cost associated with biomaterials is a factor that would restrict the global market demand to some extent during the study period.
Browse the full Regenerative Medicine Market Press Release @ : http://www.transparencymarketresearch.com/pressrelease/regenerativemedicines-market.htm In addition, based on applications the global market for regenerative medicine (bone and joint) is segmented as bone graft substitute, osteoarticular diseases, allogeneic bones, autogenic bones and others. In 2012, bone graft substitute segment accounted for the largest market share in the global regenerative medicine bone and joint application market owing to growing demand of bone graft substitute in orthopaedic surgeries. However, post implantation rejection associated with bone graft substitute is considered as a crucial factor that would restrict the global market demand of bone graft substitute. On the basis of geography, the regenerative medicine (bone and joint) market is segmented as North America, Europe, Asia-Pacific and Rest of the World (RoW). North America accounted for the largest market share for regenerative medicine (bone and joint) globally in 2012 owing to increase in orthopedic reconstructive surgeries and introduction of technologically advanced medical devices and products. According to the American Academy of Orthopedic Surgeons (AAOS), prevalence of Lumbar Spinal Stenosis (LSS) is increasing with rise in elderly population and is estimated that approximately 2.4 million Americans would be affected by LSS by 2021. It has also stated that in 1990 approximately 129,000 Total Knee Arthroplasty (TKA) surgeries were performed in the U.S.
Get Free Sample Report : http://www.transparencymarketresearch.com/sample/sample.php? flag=s&rep_id=419 Europe accounted for the second largest share in the global regenerative medicine (bone and joint) market in 2012. Large geriatric population base is one of the important factors driving the growth of regenerative medicine bone and joint application market in this region. Asia-Pacific is
Transparency Market Research
3
Regenerative Medicine Market
expected to grow at the highest CAGR from 2013 to 2019, due to large pool of potential reconstructive surgery patients and strong support from federal government. Additionally, companies are expecting large revenue with sufficient market penetration from Asia-Pacific region and thereby focusing on increasing investments in this region. For instance, in May 2013, Smith & Nephew acquired Sushrut Surgical Pvt. Ltd. an Indian medical technology company. Sushrut Surgicals product portfolio includes trauma implants and instruments, spine and limb salvage products. This acquisition would expand and enhance the product offerings of Smith & Nephew and would also assist in capturing lucrative market share in Asia-Pacific region. Major market players having presence in the global regenerative medicine (bone and joint) market include DePuy Synthes, Inc. (HEALOS Bone Graft), Medtronic, Inc. (INFUSE Bone Graft) and Zimmer Holdings, Inc. (CopiOs Bone Void Filler), Orthofix, Inc. (Trinity Evolution) and NuVasive, Inc. (Osteocel Plus). The global regenerative medicine (bone and joint) market is segmented as follows: Regenerative Medicine (Bone and Joint) Market, by Technology •
Stem Cell Therapy
•
Biomaterial
•
Tissue Engineering
Regenerative Medicine (Bone and Joint) Market, by Application •
Bone Graft Substitutes
•
Osteoarticular Diseases
•
Allogeneic Bones
•
Autogenic Bones
•
Others
Regenerative Medicine (Bone and Joint) Market, by Geography •
North America
•
Europe
Transparency Market Research
4
Regenerative Medicine Market
•
Asia-Pacific
•
Rest of the World
TABLE OF CONTENT
Chapter 1 Introduction 1.1 Report Description 1.2 Market Segmentation 1.3 Research Methodology 1.3.1 Assumptions 1.4 List of Abbreviations
Chapter 2 Executive Summary 2.1 Market Snapshot: Global Regenerative Medicine (Bone and Joint) Market (2012 & 2019) 2.2 Global Regenerative Medicine (Bone and Joint) Market, by Technology, 2012 (USD Million) 2.3 Comparative Analysis: Global Regenerative Medicine (Bone and Joint) Market, by Geography, 2012 and 2019 (Value %)
Chapter 3 Market Overview 3.1 Overview 3.2 Market Drivers
Transparency Market Research
5
Regenerative Medicine Market
3.2.1 Technological innovations in biomaterials, stem cell therapy and tissue engineering are fueling the development of regenerative medicine products 3.2.2 Growing prevalence of bone and joint disorders demand the growth of regenerative medicine products 3.2.3 Growing number of orthopedic surgeries fuels the growth of the global regenerative medicine (bone and joint) market 3.3 Restraints 3.3.1 Regulatory constraints pose a threat to the development of regenerative medicine (bone and joint) market 3.3.2 Ethical issues and post implantation infections are hindering overall market growth 3.4 Opportunities 3.4.1 Capitalization on the potential presented by emerging markets in Asia Pacific 3.5 Porter’s Five Force Analysis: Global Regenerative Medicine (Bone and Joint) Market 3.5.1 Bargaining power of suppliers 3.5.2 Bargaining power of buyers 3.5.3 Threat of new entrants 3.5.4 Threat of substitutes 3.5.5 Competitive rivalry 3.6 Competitive Landscape 3.6.1 Market Share Analysis by Key Players, 2012 (Value %) 3.7 Market Attractiveness Analysis: Global Regenerative Medicine (Bone and Joint) Market, by Geography
Transparency Market Research
6
Regenerative Medicine Market
Chapter 4 Regenerative Medicine (Bone and Joint) Market, by Technology 4.1 Introduction 4.1.1 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Technology, 2011 – 2019 (USD Million) 4.2 Stem Cell Therapy 4.2.1 Global Stem Cell Therapy Market Revenue, 2011 – 2019 (USD Million) 4.3 Biomaterials 4.3.1 Global Biomaterials Market Revenue, 2011 – 2019 (USD Million) 4.4 Tissue Engineering 4.4.1 Global Tissue Engineering Market Revenue, 2011 – 2019 (USD Million)
Chapter 5 Regenerative Medicine (Bone and Joint) Market, by Applications 5.1 Overview 5.1.1 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Applications, 2011 – 2019 (USD Million) 5.2 Bone Graft Substitutes 5.2.1 Global Bone Graft Substitute Application Market Revenue, 2011 – 2019 (USD Million) 5.3 Osteoarticular Diseases 5.3.1 Global Osteoarticular Diseases Application Market Revenue, 2011 – 2019 (USD Million)
Transparency Market Research
7
Regenerative Medicine Market
5.4 Allogeneic Bones 5.4.1 Global Allogenic Bones Application Market Revenue, 2011 – 2019 (USD Million) 5.5 Autogenic Bones 5.5.1 Global Autogenic Bone Application Market Revenue, 2011 – 2019 (USD Million) 5.6 Others 5.6.1 Global Others Application Market Revenue, 2011 – 2019 (USD Million)
Chapter 6 Regenerative Medicine (Bone and Joint) Market, by Geography 6.1 Overview 6.1.1 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Geography, 2011 – 2019 (USD Million) 6.2 North America 6.2.1 North America Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) 6.3 Europe 6.3.1 Europe Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) 6.4 Asia-Pacific 6.4.1 Asia-Pacific Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) 6.5 Rest of the World (RoW)
Transparency Market Research
8
Regenerative Medicine Market
6.5.1 RoW Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million)
Chapter 7 Recommendations 7.1 Market Strategy for Success 7.1.1 Rigorous research and development initiatives for innovative products 7.1.2 Investing in emerging economies 7.2 Barriers and Future Assumptions 7.2.1 Ethical issues pertaining to stem cell therapy hampering market growth
Chapter 8 Company Profiles 8.1 Anika Therapeutics, Inc. 8.1.1 Company Overview 8.1.2 Financial Overview 8.1.3 Product Portfolio 8.1.4 Business Strategies 8.1.5 Recent Developments 8.2 Arthrex, Inc. 8.2.1 Company Overview 8.2.2 Financial Overview
Transparency Market Research
9
Regenerative Medicine Market
8.2.3 Product Portfolio 8.2.4 Business Strategies 8.2.5 Recent Developments 8.3 Baxter International, Inc. 8.3.1 Company Overview 8.3.2 Financial Overview 8.3.3 Product Portfolio 8.3.4 Business Strategies 8.3.5 Recent Developments 8.4 CONMED Corporation 8.4.1 Company Overview 8.4.2 Financial Overview 8.4.3 Product Portfolio 8.4.4 Business Strategies 8.4.5 Recent Developments 8.5 DePuy Synthes, Inc. 8.5.1 Company Overview 8.5.2 Financial Overview 8.5.3 Product Portfolio 8.5.4 Business Strategies
Transparency Market Research
10
Regenerative Medicine Market
8.5.5 Recent Developments 8.6 Medtronic, Inc. 8.6.1 Company Overview 8.6.2 Financial Overview 8.6.3 Product Portfolio 8.6.4 Business Strategies 8.6.5 Recent Developments 8.7 Smith & Nephew plc 8.7.1 Company Overview 8.7.2 Financial Overview 8.7.3 Product Portfolio 8.7.4 Business Strategies 8.7.5 Recent Developments 8.8 Stryker Corporation 8.8.1 Company Overview 8.8.2 Financial Overview 8.8.3 Product Portfolio 8.8.4 Business Strategies 8.8.5 Recent Developments 8.9 Zimmer Holdings, Inc.
Transparency Market Research
11
Regenerative Medicine Market
8.9.1 Business Overview 8.9.2 Financial Overview 8.9.3 Product Portfolio 8.9.4 Business Strategies 8.9.5 Recent Developments List of Figures
FIG. 1 Regenerative Medicine (Bone and Joint): Market Segmentation FIG. 2 Global Regenerative Medicine (Bone and Joint) Market, by Technology, 2012 (USD Million) FIG. 3 Comparative Analysis: Global Regenerative Medicine (Bone and Joint) Market, by Geography, 2012 & 2019 (Value %) FIG. 4 Porter’s Five Forces Analysis: Global Regenerative Medicine (Bone and Joint) Market FIG. 5 Market Share Analysis: Regenerative Medicine (Bone and Joint) Market, 2012 (Value %) FIG. 6 Market Attractiveness Analysis: Global Regenerative Medicine (Bone and Joint) Market, by Geography, 2012 Value (%) FIG. 7 Global Stem Cell Therapy Market Revenue, 2011 – 2019 (USD Million) FIG. 8 Global Biomaterials Market Revenue, 2011 – 2019 (USD Million) FIG. 9 Global Tissue Engineering Market Revenue, 2011 – 2019 (USD Million) FIG. 10 Global Bone Graft Substitute Application Market Revenue, 2011 – 2019 (USD Million) FIG. 11 Global Osteoarticular Diseases Application Market Revenue, 2011 – 2019 (USD Million)
Transparency Market Research
12
Regenerative Medicine Market
FIG. 12 Global Allogeneic Bones Application Market Revenue, 2011 – 2019 (USD Million) FIG. 13 Global Autogenic Bone Application Market Revenue, 2011 – 2019 (USD Million) FIG. 14 Global Others Application Market Revenue, 2011 – 2019 (USD Million) FIG. 15 North America Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) FIG. 16 Europe Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) FIG. 17 Asia-Pacific Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) FIG. 18 RoW Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) FIG. 19 Anika Therapeutics, Inc.: Annual Revenue, 2011 – 2013 (USD Million) FIG. 20 Baxter International, Inc.: Annual Revenue, 2011 – 2013 (USD Million) FIG. 21 Conmed Corporation: Annual Revenue, 2011 – 2013 (USD Million) FIG. 22 Johnson & Johnson, Orthopedic Franchise**, Annual Revenue: 2011 – 2013 (USD Million) FIG. 23 Medtronic, Inc.: Annual Revenue, 2011 – 2013 (USD Million) FIG. 24 Smith & Nephew PLC: Annual Revenue, 2011 – 2013 (USD Million) FIG. 25 Stryker Corporation: Annual Revenue, 2011 – 2013 (USD Million) FIG. 26 Zimmer Holdings. Inc,: Annual Revenue, 2011 – 2013 (USD Million) List of Tables
Transparency Market Research
13
Regenerative Medicine Market
TABLE 1 List of Abbreviations TABLE 2 Market Snapshot: Global Regenerative Medicine (Bone and Joint) Market (2012 & 2019) TABLE 3 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Technology, 2011 – 2019 (USD Million) TABLE 4 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Applications, 2011 – 2019 (USD Million) TABLE 5 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Geography, 2011 – 2019 (USD Million)
Browse All Biotechnology Market Research Reports @ http://www.transparencymarketresearch.com/biotechnology-market-reports-18.html About Us
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forwardlooking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact Transparency Market Research
Transparency Market Research
14
Regenerative Medicine Market
90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/
Transparency Market Research
15